Target intelligence / Profile preview

E2F transcription factor 7 (E2F7)

Target
E2F7
Molecular classification
Transcription factor
01

Overview

E2F transcription factor 7 (E2F7) is an atypical member of the E2F family of transcription factors that primarily functions as a transcriptional repressor of cell cycle progression and DNA repair genes[1][3][4][6]. Unlike canonical E2F proteins, E2F7 contains two distinct DNA-binding domains and binds DNA independently of DP co-factors, preferentially associating with a subset of E2F-responsive gene promoters. It regulates transcription by directly repressing genes required for cell cycle transition (notably at G1/S), DNA replication, and DNA repair, thus integrating cell cycle control with the DNA damage response and maintenance of genomic integrity[4][5]. E2F7 also plays roles in angiogenesis and cellular polyploidization. Its aberrant expression or activity can contribute to oncogenesis, as it modulates pathways implicated in cancer and cell survival[1][4][5][6]. No drugs are currently known to specifically target E2F7.

Other names
E2F7E2F-7transcription factor E2F7
02

Mechanism of action

Transcriptional repression of E2F target genes via direct DNA binding; inhibition of cell cycle progression; repression of DNA repair gene expression[1][4][6]

03

Biological functions

Cell cycle regulationTranscriptional repressionDNA damage responseRegulation of DNA repairAngiogenesisPolyploidization
04

Disease associations

CancerOther (Aberrations in cell cycle and DNA repair are linked to oncogenesis and developmental disorders)
05

Safety considerations

Potential for impaired cell proliferation or excessive apoptosis if dysregulatedpossible genomic instability if over- or under-activated in certain contexts[1][4]
06

Biomarkers

RAD51 protein expression (as a surrogate for homologous recombination repair activity influenced by E2F7)[4]

Beyond the preview

Go deeper on E2F transcription factor 7 (E2F7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E2F transcription factor 7 (E2F7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call